Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Cancer. 2012 Apr 19;118(22):5601–5607. doi: 10.1002/cncr.27585

Table 2.

Nonhematological Grade 3 or 4 Adverse Events (n= number of pts)

Toxicity Grade 3-4 500mg 1000mg 2000mg Total
No. of patients n=52 n=6 n=54 n=112
ALT 2 2
Anorexia 1 1
Blood 1 1
Dehydration 1 1
Fatigue 3 1 4
Head/headache 2 2
Heartburn 0
Hyponatremia 1 1
Hypophosphatemia 1 1
Muscle Weakness 1 1
Musculoskeletal 1 1
Nausea 1 1
Rash 1 1
SGPT 1 1 2
Somnolence 1 1
Thrombosis 3 3
Vomiting 1 1 2
HHS Vulnerability Disclosure